of borderline significancep = 0.08
No factors were predictive of LF, although concurrent immunotherapy or targeted therapies was of borderline significance for better LC ( p = 0.08).
No factors were predictive of LF, although concurrent immunotherapy or targeted therapies was of borderline significance for better LC ( p = 0.08).
On multivariate analysis, cavity volume ( p = 0.055) and concomitant immunotherapy ( p = 0.07) showed a trend toward the development of sRN.